![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008, European Molecular Biology Organization Mre11–Rad50–Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity 1Genome Stability Unit, Clare Hall Laboratories, London Research Institute, South Mimms, Herts, UK 2Rosenstiel Center and Department of Biology, Brandeis University, Waltham, MA, USA aGenome Stability Unit, Clare Hall Laboratories, London Research Institute, Blanche Lane, South Mimms, Herts EN4 3LD, UK. Tel.: +44 1707 625748; Fax: +44 1707 625746; E-mail: vincenzo.costanzo/at/cancer.org.uk Received February 7, 2008; Accepted June 6, 2008. This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission. This article has been cited by other articles in PMC.Abstract DNA double-strand breaks (DSBs) can be processed by the Mre11–Rad50–Nbs1 (MRN) complex, which is essential to promote ataxia telangiectasia-mutated (ATM) activation. However, the molecular mechanisms linking MRN activity to ATM are not fully understood. Here, using Xenopus laevis egg extract we show that MRN-dependent processing of DSBs leads to the accumulation of short single-stranded DNA oligonucleotides (ssDNA oligos). The MRN complex isolated from the extract containing DSBs is bound to ssDNA oligos and stimulates ATM activity. Elimination of ssDNA oligos results in rapid extinction of ATM activity. Significantly, ssDNA oligos can be isolated from human cells damaged with ionizing radiation and injection of small synthetic ssDNA oligos into undamaged cells also induces ATM activation. These results suggest that MRN-dependent generation of ssDNA oligos, which constitute a unique signal of ongoing DSB repair not encountered in normal DNA metabolism, stimulates ATM activity. Keywords: ATM, DNA damage, Mre11 Introduction Chromosomal breakage induces a robust cellular response that leads to cell cycle arrest, DNA repair, or under some circumstances, apoptosis. The ataxia telangiectasia-mutated (ATM) kinase, a member of the phosphatidyl inositol 3-kinase-like kinase (PIKK) family, is central to this response (Shiloh, 2006). Essential to full ATM activation, both in vivo and in vitro, is the heterotrimeric Mre11–Rad50–Nbs1 (MRN) complex (Uziel et al, 2003; Costanzo et al, 2004a; Falck et al, 2005; Lee and Paull, 2005). The effect of MRN on ATM and its activity is likely to happen on multiple levels, as well as recruitment of ATM by Nbs1 to the sites of DNA double-strand breaks (DSBs) (Falck et al, 2005), the MRN-dependent DSB unwinding and tethering activities are essential for efficient ATM activation (Costanzo et al, 2004a; Lee and Paull, 2005). MRN complex also possesses nucleolytic activity (Paull and Gellert, 1998), and interestingly, Mre11-deficient cells complemented with an Mre11 allele carrying a mutation in the nuclease catalytic site exhibit defective ATM activation (Uziel et al, 2003). These observations support the hypothesis that MRN nuclease activity is required for ATM activation and are consistent with the recent report showing that Mirin, an inhibitor of MRN nuclease activity, suppresses ATM activation (Dupre et al, 2008). The MRN complex has both exo- and endonuclease activities (Paull and Gellert, 1998). MRN endonucleolytic activity is important for DSB resection and is enhanced by CtIP (Sartori et al, 2007), which also has nuclease activity (Takeda et al, 2007). However, although MRN has a major function in DSB resection it is unclear whether this is linked to ATM activity. In budding yeast, continuous DNA resection, recruitment of DNA repair proteins and chromatin remodelling at the site of a DSB is required to maintain an active checkpoint response (Ira et al, 2004). This suggests that DSB processing is linked to the activation of the DNA damage response. One aspect of DSB processing that has not been investigated is that endonucleolytic processing of DSBs should lead to the generation of single-stranded DNA oligonucleotides (ssDNA oligos) as by-product. The role and the fate of these ssDNA oligos inside the nucleus are currently unknown. Recently, the presence of ssDNA oligos derived from a yet unidentified DNA-processing event has been linked to the chronic activation of the ATM-dependent DNA damage response in cells deficient for Trex1 (Yang et al, 2007), which is an exonuclease that degrades ssDNA to mononucleotides (Mazur and Perrino, 2001). In addition, ATM activation has been shown to require hSSB1, a novel ssDNA-binding protein (Richard et al, 2008). Overall, these findings suggest that ssDNA molecules have an important function in promoting and sustaining ATM activity. Here, using Xenopus laevis egg extract we have investigated how DNA ends are processed and how this processing influences the MRN- and ATM-dependent DNA damage response. The Xenopus system is ideal to study the rapid activation process of ATM following addition of DNA templates to the cell-free extract (Costanzo et al, 2004b). Using this approach, we found that double- and single-stranded DNA templates inducing ATM activation are extensively processed. Surprisingly, we discovered that DNA resection leads to the production of ssDNA oligos that associate with the MRN complex and influence ATM activity. Results DNA end processing leads to formation of ssDNA oligos in Xenopus laevis egg extract Synthetic DNA molecules such as annealed oligonucleotides consisting of 70 bases of random complementary sequences (rDSBs) or poly-dA70/poly-dT70 (pA70/pT70) induce ATM-dependent DNA damage response in Xenopus egg extract (Costanzo et al, 2000; Guo and Dunphy, 2000). We monitored the fate of different DNA molecules in the extract. Equal amounts of double-stranded rDSBs and pA70/pT70 or single-stranded pA70 and pT70 DNA molecules were labelled with 32P at the 5′ or 3′ ends and incubated in egg extracts. DNA was then isolated and ran on sequencing gels. All DNA molecules were resected very rapidly in the extract resulting in the accumulation of mononucleotides and of ssDNA oligos ranging from 4 to 12 nucleotides in size (Figure 1A
Activation of ATM by different DNA structures Activation of ATM can be monitored by detection of serine 1981 phosphorylation (Bakkenist and Kastan, 2003), and ATM kinase activity can be measured by phosphorylation of a histone H2AX carboxy-terminal peptide containing the serine 139 (Costanzo et al, 2004a). We measured ATM activity triggered by different DNA molecules at increasing concentrations. rDSBs and pA70/pT70 induced phosphorylation of histone H2AX and ATM serine 1981 (Figure 2A and B
ssDNA oligos and ATM activity We then correlated the stability of DNA templates to the persistence of ATM activity. To this end, rDSBs, pA70, pT70 and single-stranded DNA molecules with random DNA sequence (R70) were incubated in the egg extract. ATM activity was monitored at various time points from DNA addition. Incubation of rDSBs, pT70, R70 and to a lesser extent of pA70 molecules in the extract resulted in stimulation of ATM activity (Figure 2C
The MRN complex mediates the effects of ssDNA oligos on ATM activity As ATM activation requires the MRN complex in Xenopus egg extract at low doses of DSBs (Costanzo et al, 2004a; Dupre et al, 2006), we were intrigued to know whether the MRN complex was promoting ATM activity induced by ssDNA oligos. Biotinylated pA70/pT70 molecules were incubated in the extract for 30 min and then removed. The MRN complex was subsequently immunoprecipitated from the extract with polyclonal antibodies raised against Mre11 (Costanzo et al, 2004a; Dupre et al, 2006). Depletion of the MRN complex led to the loss of ATM activity, suggesting that it was required to sustain ATM activity (Figure 4A
ssDNA oligos formation from chromosomal DSBs is MRN dependent To show that ssDNA oligos generation is a physiologically relevant phenomenon, we sought to establish whether ssDNA oligos could be generated following induction of chromosomal breakage. Strikingly, EcoRI treatment of sperm nuclei induced the accumulation of ssDNA oligos that were efficiently degraded by PDEI (Figure 5A
ssDNA oligos induce ATM activation in human cells To demonstrate that generation of ssDNA oligos at chromosomal breaks is a conserved phenomenon, we developed a protocol to isolate DNA oligos from human cells after induction of DSBs. Using this protocol, we could isolate ssDNA oligos from human U2OS cells treated with ionizing radiation (IR) (Figure 6A
Discussion MRN-dependent ssDNA oligo generation at DSBs Here, we have shown that DNA molecules with free DNA ends triggering ATM activation are rapidly processed resulting in the generation of ssDNA oligos. These molecules are not simple by-products of DNA resection as they participate in the ATM-dependent DNA damage response. We have demonstrated that generation of ssDNA oligos from chromosome breaks requires the MRN complex. In addition, we have shown that the MRN complex bound to ssDNA oligos promotes ATM activity, indicating that ssDNA oligos function as allosteric cofactors activating the complex. It is known that the MRN complex containing nuclease-inactive Mre11 fails to promote ATM activation (Uziel et al, 2003). In addition, Mirin, a chemical that inhibits Mre11 nuclease activity without affecting MRN and ATM binding to DSBs, suppresses ATM activity (Dupre et al, 2008). Our findings are consistent with the requirement for the MRN complex nuclease activity in the ATM activation process. Once ssDNA oligos have been generated, they remain associated with the MRN complex and probably promote a stable conformation capable of inducing continuous stimulation of ATM molecules. This process, likely, requires the generation of a limited amount of ssDNA oligos bound to MRN complex and does not require extensive resection to activate a large number of ATM molecules. This model is compatible with the lack of extensive resection in G1-arrested cells in which ATM can be activated (Jazayeri et al, 2006; Sartori et al, 2007). In addition, we show that ssDNA oligo formation can take place also in G1-arrested cells after treatment with IR. This is consistent with the recently reported resection of ‘ragged' DNA ends induced by IR in G1-arrested cells (Barlow et al, 2008). ssDNA oligos produced at DSBs could interact with one or more subunits of the MRN complex that have DNA-binding domains. The binding of dinucleoside polyphosphates to the MRN complex through the Rad50 subunit has recently been demonstrated and suggests that the activities of the MRN complex are regulated by different nucleotide metabolites (Bhaskara et al, 2007). Alternatively, it is also possible that the MRN complex is not the only mediator of ssDNA oligos' effect on ATM. ssDNA oligos might also influence ATM activity binding other targets such as the recently discovered ssDNA-binding protein hSSB1, which has high affinity for small ssDNA oligos and is required for ATM activation (Richard et al, 2008). Overall, these observations are consistent with reports showing the existence of a multiple step activation mode of ATM (Dupre et al, 2006; Berkovich et al, 2007) and suggest that ssDNA can trigger an initial activation of ATM, which can be amplified and maintained by ssDNA oligos generation. ssDNA oligos may increase the activity of ATM molecules already bound to DSBs or facilitate the activation of inactive ATM molecules that have not yet engaged DSBs (Figure 7
As far as the mechanism of ssDNA oligo generation is concerned, the detection of ssDNA oligos from internally labelled DNA indicates that they are produced by the combined actions of endo- and exonuclease activities described for the MRN complex. The MRN complex might exert an effect on single-stranded DNA generated by helicase-mediated unwinding of DSBs. Interestingly, we found that generation of ssDNA oligos from chromosomal DSBs is entirely dependent upon MRN, whereas small amounts of ssDNA oligos generated from synthetic DNA templates can still be detected in the absence of MRN (data not shown). This indicates that MRN complex activity is specific for DSB processing that arise in the context of the chromatin, consistent with its chromatin-remodelling activities (Tsukuda et al, 2005). ssDNA oligos turnover is linked to ATM activation status An important aspect of ssDNA oligo metabolism is their turnover as the persistence of ssDNA oligos is correlated with the activation status of ATM. We showed that in Xenopus egg extract, exogenous synthetic small ssDNA oligos are rapidly degraded, whereas ssDNA oligos derived from the resection of larger DNA templates are more stable. This is likely due to their association with factors involved in DNA resection such as the MRN complex or other ssDNA-binding proteins. Interestingly, the ssDNA-binding protein hSSB1, which is highly conserved in Xenopus, has a higher binding affinity for poly-pyrimidine than for poly-purine containing ssDNA molecules (Richard et al, 2008). The association of ssDNA oligos to proteins such as hSSB1, if proven, might explain the higher intrinsic stability and efficiency at stimulating ATM activity of poly-pyrimidine pT70 compared with poly-purine pA70 oligos in the egg extract. Predictably, the elimination of ssDNA oligos would be required for efficient inactivation of ATM once DSBs have been repaired, whereas the persistence of ssDNA oligos would maintain ATM active. ssDNA oligos elimination could be mediated by an exonuclease capable of degrading ssDNA oligos. Among known nucleases, Trex1, which has an activity similar to PDEI, can degrade ssDNA oligos (Mazur and Perrino, 2001). Mutations in Trex1 are responsible for the Aicardi–Goutieres syndrome, a complex human disease that recapitulates the effects of an embryonic response to a viral DNA infection (Crow et al, 2006). The deficiency of Trex1 activity leads to the accumulation of free ssDNA oligos and this correlates with chronic stimulation of the ATM-dependent DNA damage response (Yang et al, 2007). Therefore, Trex1 is an ideal candidate for the regulation of ssDNA oligos stability and, indirectly, ATM activity (Figure 7 ssDNA oligos as an alarm signal The creation of ssDNA oligos during the resection of DNA undergoing repair, either from 5′ to 3′ processing of DSBs or possibly from enlarging gaps in other forms of DNA repair is a unique signal of DNA damage. Whereas mononucleotides are produced by normal DNA metabolism, these ssDNA oligos are only present when DNA damage is being processed. ssDNA oligos could function as an alarm signal that promotes full activation of the DNA damage response. Thus, whereas DSB ends and ssDNA are necessary to establish a platform to assemble factors required for the localized activation of the checkpoint and for the repair of the damage, a widespread and efficient DNA damage response—which should be turned off when repair is complete—takes advantage of DNA species that are only produced while repair is ongoing. The fact that single-stranded circular DNA, which is not degraded, is unable to trigger sustained ATM activation is consistent with the hypothesis that ssDNA in the absence of DNA processing is not sufficient to activate ATM. In budding yeast, where repair can be carefully monitored, resection continues at a rate of 4 kb/h from DSB ends for as long as it takes the process of repair to be completed, and the checkpoint is turned off soon after repair is complete (Vaze et al, 2002; Keogh et al, 2006). In the absence of yeast Mre11, the DNA damage checkpoint is initiated, but not maintained as in wild-type cells (Lee et al, 1998; D'Amours and Jackson, 2001), indicating a role for Mre11 in sustaining the checkpoint. Importantly, ssDNA oligos can also be observed following induction of DSBs in human cells, indicating that this is a conserved physiological phenomenon. The introduction of ssDNA oligos in cancer cells could be therapeutically exploited to enhance DNA damage response without producing further damage to the genome. Materials and methods Xenopus egg extract The egg extracts were prepared as previously described (Costanzo et al, 2004a). Interphase extract was obtained by releasing CSF-arrested extract with 0.4 mM CaCl2. DNA structures All DNA oligos were obtained from Sigma-Genosys. Random 70 mer complementary single-stranded DNA molecules (rDSB) had the following sequence: 5′-TGGGTCTCTCTGGGCTTCTGGTCTCCTGGACAACA GATCAAGGCAACCATGGCCCACACACTCAAGGGC-3′ 5′-GCCCTTGAGTGTGTGGGCCATGGTTGCCTTGATCTG TTGTCCAGGAGACCAGAAGCCCAGAGAGACCCA-3′ Equimolar amounts of single-stranded DNA oligos were annealed in a buffer containing 10 mM HEPES (pH 7.5) and 5 mM MgCl2 at 95°C for 1 min, 65°C for 10 min, 37°C for 10 min and 22°C for 10 min in a PCR Thermocycler to obtain double-stranded DNA poly-dA70/dT70 and rDSB. Biotinylated poly-dA70/dT70 was obtained by annealing 3′-biotinylated poly-dT70 to poly-dA70. DNA concentration was measured in the Nanodrop spectrophotometer. H2AX kinase assay Interphase egg extracts were incubated with DNA structures as indicated at 22°C. The extract (2 μl) was mixed with 20 μl of EB kinase buffer (20 mM HEPES (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 1 mM DTT and 10 mM MnCl2) supplemented with 0.5 mg/ml histone H2AX peptide (Sigma-Genosys), 50 μM ATP and 10 μCi of g-32P-ATP 10 μCi/μl (greater than 3000 Ci/mmol). The samples were incubated at 30°C for 5 min, and reactions were spotted on p81 phosphocellulose filter paper (Upstate Biotechnology). Filters were air-dried and washed three times in 5% phosphoric acid. Radioactivity was quantified in a scintillation counter. PARP inhibitor was obtained from BIOMOL and RNAseA from Qiagen. The extract used to measure H2AX phosphorylation was pre-incubated twice for 20 min at 4°C with a volume of streptavidin-coated beads (Dynal) coupled to 5′ biotinylated double-stranded 20 mer oligos (with a sequence corresponding to the first 20 nucleotides of rDSB oligos) that were then removed to eliminate H2AX kinase activity due to DNA-PK (Dupre et al, 2006). DNA labelling Poly-dA70/dT70 poly-dA70, poly-dT70 and rDSB were labelled at the 5′ end using T4 polynucleotide kinase. Briefly, 10 ng of DNA was incubated with 30 U T4 kinase (NEB) for 4 h at 37°C in 30 μl reaction in the T4 kinase buffer (NEB) in the presence of 10 μCi of g-32P-ATP 10 μCi/μl (greater than 3000 Ci/mmol). Excess of enzyme and long incubation time ensured stoichiometric labelling of the DNA. Poly-dA70/dT70 poly-dA70, poly-dT70 and rDSB 3′ end labelling was done by incubating 10 ng of DNA with 20 U TdT (Fermentas) for 4 h at 37°C in 30 μl reaction in the presence of TdT reaction buffer (Fermentas) and 10 μCi of alpha-32P-ddATP 10 μCi/μl (greater than 3000 Ci/mmol). Labelled DNA was purified through G25 gel filtration columns (Amersham). DNA concentration was measured in the Nanodrop spectrophotometer. 32P-labelled poly-dA70/dT70 was obtained by annealing 3′-32P-labelled poly-dT70 to poly-dA70. 32P-Labelled biotinylated poly-dA70/dT70 was obtained by annealing 3′-biotinylated poly-dA70 to 3′-32P-labelled poly-dT70. For internally labelled oligos, a 35-mer oligo (5′-TGTCTGACCTTGTTTTTGGGACGTCTACTCATCTC-3′) was 32P labelled at the 5′ end with T4 polynucleotide kinase. The labelled oligo was annealed to a 70-mer oligo (5′-GAGATGAGTAGACGTCCCAAAAACAAGGTCAGACATCGTGACACA TTCTGTCCGGTCTAGGGCATGGATG-3′) to generate a double-stranded oligo with a 35-mer overhang. This structure was then annealed to another 35-mer oligo (5′-CATCCATGCCCTAGACCGGACAGAATGTGTCACGA-3′), complementary to the overhang region, followed by a ligase reaction to join the two adjacent 35-mer oligos. The excess ssDNA in the reaction was removed with ExoI treatment. Labelled DNA was purified through G25 gel filtration columns (Amersham). DNA-processing reaction Poly-dA70/dT70, poly-dA70, poly-dT70 or rDSB labelled at the 5′ or 3′ end was mixed with 10 μl of the egg extract and incubated at 22°C for 0, 1, 30, 60 and 90 min. Reactions were stopped with 40 μl stop buffer (0.5% SDS, 80 mM Tris pH 8.0 and EDTA 8 mM). Here, 10 μl of the reaction was mixed with Tris–urea denaturing loading buffer (Invitrogen), heated at 70°C for 3 min and run on 22% Tris–urea acrylamide sequencing gel using a Bio-Rad apparatus. Alternatively, 15% TBE–urea acrylamide or TBE–acrylamide pre-cast gels from Invitrogen were used. Oligonucleotide DNA marker (Amersham) used was labelled with TdT as described above. Gels were washed in a fixative (35% MetOH, 18% acetic acid) for 30 s, wrapped in saran-wrap and immediately exposed. Purified 5′-nucleotidase-free PDEI derived from Crotalus adamanteus venom (Sigma-Genosys) was a gift from T Lindhal. The enzyme was typically used at 0.001–0.002 U/μl. ATM, ATR and Mre11 depletions and western blots For Mre11, ATM and ATR depletions, 100 μl of interphase extracts was incubated with 50 μl protein A Sepharose beads coupled to 100 μl of anti-X-Mre11, anti-X-ATM or anti-X-ATR serum for 45 min at 4°C twice. For mock depletion, protein A Sepharose beads washed in PBS were used. Mre11 antibodies and production of recombinant histidine-tagged MRN complex have been previously described (Costanzo et al, 2004a). Anti-human Mre11 antibodies were from Bethyl. Anti-X-ATM and anti-X-ATR polyclonal antibodies were previously described (Trenz et al, 2006). Detection of ATM pSerine 1981 by western blot was obtained with mouse anti-ATM pSerine 1981 (Rockland Immunochemicals) overnight in blocking solution using Advanced ECL (Amersham). Isolation of DNA oligonucleotides DNA oligonucleotides associated with Mre11 immunoprecipitates were detected as following: 100 ng poly-dA70/dT70 was 32P-labelled at 3′ end of the poly-dT70 using TdT as described above. The reaction was scaled up by a factor of 10. 32P-labelled poly-dA70/dT70 (100 ng) was incubated in 100 μl egg extracts for 30 min. Protein A Sepharose beads (50 μl) coupled to 100 μl of anti-X-Mre11 serum were then added to the extracts. For mock depletions, protein A Sepharose beads washed in PBS were used. Reactions were incubated for 45 min at 22°C. Sepharose beads were then isolated by 1 min centrifugation at 1000 r.p.m. at 4°C and washed three times with PBS supplement with 0.4% NP40. The samples were resuspended in TBE–urea loading buffer (Invitrogen), heated at 70°C for 3 min and run on a 15% TBE–urea acrylamide pre-cast gels (Invitrogen). DNA oligonucleotides accumulated in response to EcoRI treatment were isolated as follows. Sperm nuclei were incubated in untreated, mock-depleted or Mre11-depleted extracts at 4000 nuclei/μl for 30 min at 22°C and the extract was supplemented with 0.2 U/μl of EcoRI and incubated for a further 60 min. The extract was then resuspended in 40 mM HEPES-KOH pH 7.5, 15 mM MgCl2, 100 mM KCl, 20 mM EDTA and 1% Triton X-100 and incubated on ice for 10 min. The samples were centrifuged at 6000 g for 5 min and the supernatant was collected and labelled with TdT. Briefly, 50 μl of TdT reaction mixture (30 U TdT, TdT reaction buffer and 50 μCi of alpha-32P-ddATP 10 μCi/μl greater than 3000 Ci/mmol). Reactions were incubated at 37°C overnight. Labelled DNA was purified through G25 gel filtration columns (Amersham). The samples were loaded on 15% Tris–urea acrylamide gels and run for 1 h at 200V. Labelled DNA was transferred to Hybond-N+ membrane (Amersham) for 2 h at 300 V in 1 × TBE buffer. The membrane was then heated at 80°C for 2 h and exposed (Figure 5A and B Isolation of DNA oligonucleotide from human cells was obtained as follows: 3 × 107 human U2OS cells arrested by confluence density or synchronized in G1 with 500 μM mimosine (Sigma-Genosys) were irradiated with 10 Gy using a caesium 137 source or mock treated. G1 arrest was monitored with standard protocols using a FACS sorter. The cells were washed with ice-cold PBS once, harvested with a cell scraper in PBS and collected by centrifugation. The cell pellets were then treated for 5 min with lysis buffer (2% sodium dodecyl sulphate, 20 mM EDTA, 20 mM EGTA, 50 mM Tris–HCl, pH 7.5). Tubes were incubated at room temperature for 10 min. Then 25 μl 5 M NaCl was added and tubes were gently inverted three times and stored for 24 h at 4°C. The genomic DNA was then pelleted following centrifugation for 30 min at 9000 g at 4°C. The supernatant was harvested and the small DNA species were extracted with one volume of phenol–chloroform followed by ethanol precipitation overnight at −20°C. DNA was recovered following centrifugation at 9000 g at 4°C for 30 min. DNA was washed once with 70% ethanol and after repeated centrifugation at 9000 g at 4°C for 30 min, the pelleted DNA was resuspended in 50 μl TdT labelling mix (30 U TdT, TdT reaction buffer and 50 μCi of alpha-32P-ddATP 10 μCi/μl greater than 3000 Ci/mmol) as per the Fermentas manufacturer's protocol and incubated at 37°C for 30 min. RNAse A was then added to the final concentration of 1 mg/ml. The labelling reaction was stopped using 5 μl 0.5 M EDTA. Formamide loading buffer (5 μl) was added to 5 μl of the labelling reaction. The samples were loaded on 15% Tris–urea acrylamide gels and run for 1 h at 200 V. Gels were washed in 35% methanol, 15% acetic acid, wrapped in saran-wrap and immediately exposed. DNA oligonucleotide injection and immunofluorescence Human U2OS cell derivatives were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The cells were grown on poly-L lysine-treated cover slips for at least 48 h in DMED supplemented with 10% FCS prior to manipulations. For microinjections, injection mixtures (10 μl of Alexa Fluor 488 chicken anti-goat IgG (Molecular Probes) plus 5 μl of DNA at 5 μg/μl) were loaded onto Femtotip I (Eppendorf) and attached to InjectMan NI2 System (Eppendorf) connected to Zeiss Axiovert 200 microscope. The cells were injected into the cytoplasm at ~100–150 hPa injection pressure. For each experiment, about 200 cells were injected and after 30 min cells were fixed in ice-cold 50% methanol–50% acetone mixtures for 10 min on ice. Following fixation, the cells were washed extensively with PBS and incubated for 30 min with blocking solution containing 5% (w/v) non-fat milk in TBST (TBS plus 0.1% Tween-20). The cells were then incubated with mouse anti-ATM pSerine 1981 (Rockland Immunochemicals) overnight in blocking solution. For secondary detection, we used Alexa Fluor 594 chicken anti-mouse IgG (Molecular Probes). The cells were visualized using a ZeissLSM 510 Confocal microscope. Supplementary Figures Click here to view.(3.2M, pdf) Supplementary Figure Legend Click here to view.(36K, doc) Acknowledgments We thank the members of the Genome Stability Lab for critical discussions, J Gautier for the anti-Xenopus ATM serum and T Paull for Mre11, Nbs1 and Rad50 baculoviruses. This study was supported by the Cancer Research UK, the Lister Institute of Preventive Medicine research prize, the EMBO Young Investigator Program and the European Research Council (ERC) start-up grant awarded to VC. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Trends Biochem Sci. 2006 Jul; 31(7):402-10.
[Trends Biochem Sci. 2006]EMBO J. 2003 Oct 15; 22(20):5612-21.
[EMBO J. 2003]PLoS Biol. 2004 May; 2(5):E110.
[PLoS Biol. 2004]Nature. 2005 Mar 31; 434(7033):605-11.
[Nature. 2005]Science. 2005 Apr 22; 308(5721):551-4.
[Science. 2005]Mol Cell. 2000 Sep; 6(3):649-59.
[Mol Cell. 2000]Mol Biol Cell. 2000 May; 11(5):1535-46.
[Mol Biol Cell. 2000]Nature. 2003 Jan 30; 421(6922):499-506.
[Nature. 2003]PLoS Biol. 2004 May; 2(5):E110.
[PLoS Biol. 2004]Cancer Res. 2004 Dec 15; 64(24):9152-9.
[Cancer Res. 2004]EMBO J. 2006 Dec 13; 25(24):5775-82.
[EMBO J. 2006]Mol Biol Cell. 2000 May; 11(5):1535-46.
[Mol Biol Cell. 2000]Nat Struct Mol Biol. 2006 May; 13(5):451-7.
[Nat Struct Mol Biol. 2006]J Biol Chem. 1959 Aug; 234(8):2105-13.
[J Biol Chem. 1959]J Biol Chem. 1959 Aug; 234(8):2114-7.
[J Biol Chem. 1959]PLoS Biol. 2004 May; 2(5):E110.
[PLoS Biol. 2004]Nat Struct Mol Biol. 2006 May; 13(5):451-7.
[Nat Struct Mol Biol. 2006]J Biol Chem. 2004 Dec 17; 279(51):53353-64.
[J Biol Chem. 2004]EMBO J. 2003 Oct 15; 22(20):5612-21.
[EMBO J. 2003]Nat Chem Biol. 2008 Feb; 4(2):119-25.
[Nat Chem Biol. 2008]Nat Cell Biol. 2006 Jan; 8(1):37-45.
[Nat Cell Biol. 2006]Nature. 2007 Nov 22; 450(7169):509-14.
[Nature. 2007]Mol Cell. 2008 Apr 11; 30(1):73-85.
[Mol Cell. 2008]Nature. 2008 May 29; 453(7195):677-81.
[Nature. 2008]Nat Struct Mol Biol. 2006 May; 13(5):451-7.
[Nat Struct Mol Biol. 2006]Nat Cell Biol. 2007 Jun; 9(6):683-90.
[Nat Cell Biol. 2007]Nature. 2005 Nov 17; 438(7066):379-83.
[Nature. 2005]Nature. 2008 May 29; 453(7195):677-81.
[Nature. 2008]J Biol Chem. 2001 May 18; 276(20):17022-9.
[J Biol Chem. 2001]Nat Genet. 2006 Aug; 38(8):917-20.
[Nat Genet. 2006]Cell. 2007 Nov 30; 131(5):873-86.
[Cell. 2007]Mol Cell. 2002 Aug; 10(2):373-85.
[Mol Cell. 2002]Nature. 2006 Jan 26; 439(7075):497-501.
[Nature. 2006]Cell. 1998 Aug 7; 94(3):399-409.
[Cell. 1998]Genes Dev. 2001 Sep 1; 15(17):2238-49.
[Genes Dev. 2001]PLoS Biol. 2004 May; 2(5):E110.
[PLoS Biol. 2004]Nat Struct Mol Biol. 2006 May; 13(5):451-7.
[Nat Struct Mol Biol. 2006]PLoS Biol. 2004 May; 2(5):E110.
[PLoS Biol. 2004]EMBO J. 2006 Apr 19; 25(8):1764-74.
[EMBO J. 2006]